Epidemiology of Heart Failure and the Discovery of the Cardioprotective Effects of SGLT2 Inhibitors

被引：0
作者：
Butler, Javed [1 ,2 ,3 ]
Rich, Jonathan [4 ]
机构：
[1] Baylor Scott & White Res Inst, Dallas, TX 75204 USA
[2] Baylor Scott & White Hlth, Dallas, TX 75246 USA
[3] Univ Mississippi, Sch Med, Jackson, MS 39216 USA
[4] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Cardiol, Chicago, IL 60611 USA
来源：
JACC-HEART FAILURE | 2024年 / 12卷 / 06期
关键词：
cardiovascular outcomes; heart failure; SGLT2; inhibitors; GLUCOSE; PHARMACODYNAMICS; PHARMACOKINETICS; EMPAGLIFLOZIN;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S1 / S3
页数：3
相关论文
共 27 条
  • [1] Burden of medical co-morbidities and benefit from surgical revascularization in patients with ischaemic cardiomyopathy
    Ambrosy, Andrew P.
    Stevens, Susanna R.
    Al-Khalidi, Hussein R.
    Rouleau, Jean L.
    Bouabdallaoui, Nadia
    Carson, Peter E.
    Adlbrecht, Christopher
    Cleland, John G. F.
    Dabrowski, Rafal
    Golba, Krzysztof S.
    Pina, Ileana L.
    Sueta, Carla A.
    Roy, Ambuj
    Sopko, George
    Bonow, Robert O.
    Velazquez, Eric J.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (03) : 373 - 381
  • [2] Empagliflozin in Heart Failure with a Preserved Ejection Fraction
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Ferreira, Joao P.
    Bocchi, Edimar
    Boehm, Michael
    Brunner-La Rocca, Hans-Peter
    Choi, Dong-Ju
    Chopra, Vijay
    Chuquiure-Valenzuela, Eduardo
    Giannetti, Nadia
    Gomez-Mesa, Juan Esteban
    Janssens, Stefan
    Januzzi, James L.
    Gonzalez-Juanatey, Jose R.
    Merkely, Bela
    Nicholls, Stephen J.
    Perrone, Sergio V.
    Pina, Ileana L.
    Ponikowski, Piotr
    Senni, Michele
    Sim, David
    Spinar, Jindrich
    Squire, Iain
    Taddei, Stefano
    Tsutsui, Hiroyuki
    Verma, Subodh
    Vinereanu, Dragos
    Zhang, Jian
    Carson, Peter
    Lam, Carolyn Su Ping
    Marx, Nikolaus
    Zeller, Cordula
    Sattar, Naveed
    Jamal, Waheed
    Schnaidt, Sven
    Schnee, Janet M.
    Brueckmann, Martina
    Pocock, Stuart J.
    Zannad, Faiez
    Packer, Milton
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16) : 1451 - 1461
  • [3] Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
    Bhatt, Deepak L.
    Szarek, Michael
    Steg, P. Gabriel
    Cannon, Christopher P.
    Leiter, Lawrence A.
    McGuire, Darren K.
    Lewis, Julia B.
    Riddle, Matthew C.
    Voors, Adriaan A.
    Metra, Marco
    Lund, Lars H.
    Komajda, Michel
    Testani, Jeffrey M.
    Wilcox, Christopher S.
    Ponikowski, Piotr
    Lopes, Renato D.
    Verma, Subodh
    Lapuerta, Pablo
    Pitt, Bertram
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (02) : 117 - 128
  • [4] Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes
    Cannon, Christopher P.
    Pratley, Richard
    Dagogo-Jack, Samuel
    Mancuso, James
    Huyck, Susan
    Masiukiewicz, Urszula
    Charbonnel, Bernard
    Frederich, Robert
    Gallo, Silvina
    Cosentino, Francesco
    Shih, Weichung J.
    Gantz, Ira
    Terra, Steven G.
    Cherney, David Z. I.
    McGuire, Darren K.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (15) : 1425 - 1435
  • [5] Multimorbidity in Heart Failure: A Community Perspective
    Chamberlain, Alanna M.
    St Sauver, Jennifer L.
    Gerber, Yariv
    Manemann, Sheila M.
    Boyd, Cynthia M.
    Dunlay, Shannon M.
    Rocca, Walter A.
    Rutten, Lila J. Finney
    Jiang, Ruoxiang
    Weston, Susan A.
    Roger, Veronique L.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2015, 128 (01) : 38 - 45
  • [6] Pharmacokinetics and Pharmacodynamics of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, in Subjects With Type 2 Diabetes Mellitus
    Devineni, Damayanthi
    Curtin, Christopher R.
    Polidori, David
    Gutierrez, Maria J.
    Murphy, Joseph
    Rusch, Sarah
    Rothenberg, Paul L.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (06) : 601 - 610
  • [7] 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
    Heidenreich, Paul A.
    Bozkurt, Biykem
    Aguilar, David
    Allen, Larry A.
    Byun, Joni J.
    Colvin, Monica M.
    Deswal, Anita
    Drazner, Mark H.
    Dunlay, Shannon M.
    Evers, Linda R.
    Fang, James C.
    Fedson, Savitri E.
    Fonarow, Gregg C.
    Hayek, Salim S.
    Hernandez, Adrian F.
    Khazanie, Prateeti
    Kittleson, Michelle M.
    Lee, Christopher S.
    Link, Mark S.
    Milano, Carmelo A.
    Nnacheta, Lorraine C.
    Sandhu, Alexander T.
    Stevenson, Lynne Warner
    Vardeny, Orly
    Vest, Amanda R.
    Yancy, Clyde W.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (17) : E253 - E421
  • [8] Forecasting the Impact of Heart Failure in the United States A Policy Statement From the American Heart Association
    Heidenreich, Paul A.
    Albert, Nancy M.
    Allen, Larry A.
    Bluemke, David A.
    Butler, Javed
    Fonarow, Gregg C.
    Ikonomidis, John S.
    Khavjou, Olga
    Konstam, Marvin A.
    Maddox, Thomas M.
    Nichol, Graham
    Pham, Michael
    Pina, Ileana L.
    Trogdon, Justin G.
    [J]. CIRCULATION-HEART FAILURE, 2013, 6 (03) : 606 - 619
  • [9] Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks' treatment with empagliflozin once daily in patients with type 2 diabetes
    Heise, T.
    Seewaldt-Becker, E.
    Macha, S.
    Hantel, S.
    Pinnetti, S.
    Seman, L.
    Woerle, H. J.
    [J]. DIABETES OBESITY & METABOLISM, 2013, 15 (07) : 613 - 621
  • [10] Overview of the socio-economic consequences of heart failure
    Hessel, Franz P.
    [J]. CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2021, 11 (01) : 254 - 262
123